Assess Lot-to-Lot Consistency of 3 Lots (Double Blind Design) of GSK Biologicals' 10-Valent Pneumococcal Vaccine and Evaluate Non-Inferiority to Prevenar (Single Blind Design) When Administered as 3-Dose Primary Immunization Course Before 6 Months of Age.
Latest Information Update: 05 Sep 2023
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; DTaP vaccine; Pneumococcal 7-valent CRM197 vaccine conjugate
- Indications Diphtheria; Pertussis; Pneumococcal infections; Streptococcal infections; Tetanus
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline; GSK